VA NEPHRON D Sttudy in NEJM: Combination ACE-I and ARB treatment for diabetic nephropathy with proteinuria found to be harmful.
NEJM: Conclusions. Combination therapy with an ACE inhibitor and an ARB was associated with an increased risk of adverse events among patients with diabetic nephropathy